| Utestående aktier | 26,151,724 shares |
| Insideraktier | 11 497 610 shares |
| Insynsägande | 43,97 % |
| Totalt antal insynspersoner | 23 |
Insider Sentiment Score
Insider sentiment score hittar de företag som köps av foretagsinsynspersoner.
Det är resultatet av en sofistikerad, kvantitativ multifaktormodell som identifierar företag med de högsta nivåerna av insiderackumulation. Poängmodellen använder en kombination av nettoantalet insiders som köpt de föregående 90 dagarna, det totala antalet aktier som köpts i procent av aktiekapitalet och det totala antalet aktier som ägs av insiders. Siffran sträcker sig från 0 till 100, med högre siffror som indikerar en högre nivå av ackumulering för sina kamrater, och 50 är genomsnittet.
Uppdateringsfrekvens: Dagligen
Se Insiders Top Picks, som ger en lista över företag med högsta insiderackumulation.
Office Sentiment Score
Officersentiment Score hittar företag som köps av Corporate Officers.
Per definition Corporate Officers är Corporate Insiders, men till skillnad från vissa av de andra Insiders (10 % aktieägare och styrelseledamöter), arbetar ämbetsmän för företaget dagligen och de använder sina egna pengar när de handlar . (10 % aktieägare och styrelseledamöter är ofta fondförvaltare som förvaltar andras pengar.) Som sådan är insideraffärer som görs av tjänstemän mycket mer betydelsefulla och bör behandlas på lämpligt sätt.
Liksom Insider Sentiment Score är Officer Sentiment Score resultatet av en sofistikerad, kvantitativ multifaktormodell som identifierar företag med de högsta nivåerna av officersackumulering.
Uppdateringsfrekvens: Dagligen
Se insiderns bästa val, vilket ger en lista över företag med högsta insider sentiment.
Viktiga insidernyckeltal
Denna kort visar hur företaget rankas längs olika insidernyckeltal. Procenttilrankningen visar hur detta företag jämförs med andra företag på USA-marknaden. Högre rankingar indikerar bättre situationer.
Till exempel anses det allmänt att insiderköp är en positiv indikator, så företag med mer insiderköp skulle rankas högre än företag med mindre insiderköp (eller til och med insiderförsäljning).
Procent av flytande köpta av insiders (ranking)
0.000 %( )
5424 out of 11220Procentandelen av aktier köpta av insiders är det totala antalet aktier som köpts av insiders minus det totala antalet aktier som sålts av insiders under de senaste 90 dagarna, dividerat med det totala antalet aktier och multiplicerat med 100.
Insiderhandelsdiagram
CVRx, Inc. insideraffärer visas i följande diagram. Insiders är tjänstemän, styrelseledamöter eller betydande investerare i ett företag. I allmänhet är det i allmänhet olagligt för insiders att göra affärer i sina företag baserat på väsentlig, icke-offentlig information. Detta betyder inte att det är olagligt för dem att göra några affärer i sina egna företag. De måste dock rapportera alla affärer till SEC via ett formulär 4.
Insiderlista och lönsamhetsstatistik
Den här tabellen visar listan över kända insiders och genereras automatiskt från anmälningar som avslöjas till SEC. Förutom namnen, den senaste titeln och direktören, tjänstemannen eller ägarbeteckningen på 10 %, tillhandahåller vi de senaste avslöjade innehaven. Dessutom, när det är möjligt tillhandahåller vi insiderns historiska handelsresultat. Det historiska handelsresultatet är ett vägt genomsnitt av resultatet för faktiska köptransaktioner på den öppna marknaden som insidern gjort. För mer information om hur detta beräknas, titta på detta YouTube-webinarium.
See our leaderboard of most profitable insider traders.
| Insider | Genomsnitt vinst (%) | Aktier Ägda |
Delad Justerad |
|---|---|---|---|
| Adamson Philip B. Chief Medical Officer - [O] | 20 000 | 20 000 | |
| John Brintnall CHIEF STRATEGY OFFICER AND SEC - [O] | 21 901 | 21 901 | |
| Dean Bruhn-ding VP of Reg. Affairs and QA - [O] | 54 648 | 54 648 | |
| Ali Behbahani Director - [D] | 316 | 316 | |
| Brent Binkowski CHIEF OPERATING OFFICER - [O] | 16 600 | 16 600 | |
|
Plc Glaxosmithkline
10% Owner -
|
1 007 583 | 1 007 583 | |
| Liz Galle VP OF GLOBAL CLINICAL RESEARCH - [O] | 778 | 778 |
| Insider | Genomsnitt vinst (%) | Aktier Ägda |
Delad Justerad |
|---|---|---|---|
| Kevin Hykes PRES & CEO, Director - [D] [O] | 133 000 | 133 000 | |
|
& Johnson Johnson
10% Owner -
|
4 103 430 | 4 103 430 | |
| Jain Mudit K. Director - [D] | 5 050 | 5 050 | |
| Robert Allen John Chief Revenue Officer - [O] | 55 000 | 55 000 | |
|
Johnson & Johnson Innovation - JJDC, Inc.
10% Owner -
|
3 495 575 | 4 103 430 | |
|
Nea Partners 10 L P
10% Owner -
|
173 388 | 173 388 | |
| John M Nehra Director - [D] | 28 266 | 28 266 | |
|
Enterprise Associates 10 L P New
10% Owner -
|
2 026 083 | 2 026 083 |
| Insider | Genomsnitt vinst (%) | Aktier Ägda |
Delad Justerad |
|---|---|---|---|
| Nielsen Kirk G. Director - [D] | 1 910 134 | 1 910 134 | |
| Jared Oasheim CHIEF FINANCIAL OFFICER - [O] | 37 447 | 37 447 | |
| Palmer Craig E. SVP, U.S. SALES - [O] | 1 229 | 1 229 | |
| Geoffrey B Pardo Director - [D] | 1 829 022 | 1 829 022 | |
|
Scott D Sandell
10% Owner -
|
173 388 | 173 388 | |
| Joseph P Slattery Director - [D] | 30 645 | 30 645 | |
| Paul Verrastro CHIEF MKTG & STRAT OFFICER - [O] | 16 835 | 16 835 | |
| Nadim Yared CHIEF EXECUTIVE OFFICER, Director - [D] [O] | 26 255 | 26 255 |
Report errors via our new Insider Auditing Tool
Track Records av insiderköp - Kortsiktig vinstanalys
I denna sektion analyserar vi lönsamheten för varje oplanerat, öppet-marknads insiderköp gjorda i CVRX / CVRx, Inc.. Denna analys hjälper till att förstå om insidern konsekvent genererar onormala avkastningar och är värd att följa. Denna analys är för ett år efter varje handel, och resultaten är teoretiska .
Tabellen nedan visar de senaste köpen på öppna marknaden som inte var en del av en automatisk handelsplan.
Justeringar av aktierär de justerade aktierna efter justerat pris. Justeringar av aktierär de justerade aktierna efter uppdelning.
Track Records av insiderförsäljning - Kortsiktig förlustanalys
I denna sektion analyserar vi lönsamheten för varje oplanerat, öppet-marknads insiderköp gjorda i CVRX / CVRx, Inc.. Denna analys hjälper till att förstå om insidern konsekvent genererar onormala avkastningar och är värd att följa. Denna analys är för ett år efter varje handel, och resultaten är teoretiska .
Tabellen nedan visar de senaste försäljningarna på öppna marknaden som inte var en del av en automatisk handelsplan.
Justeringar av aktierär de justerade aktierna efter justerat pris. Justeringar av aktierär de justerade aktierna efter uppdelning.
Transaktionshistorik
Klicka på länkikonen för att se hela transaktionshistoriken. Transaktioner som rapporteras som en del av en automatisk handelsplan 10b5-1 kommer att ha ett X i kolumnen markerad 10b-5.
| Fil datum |
Handel datum |
Schema | Insider | Ticker | Värdepappertitel | Kod | Direkta | Utövningspris | Enhet pris |
Enheter ändrad |
Värde ändrad (1K) |
Kvarvarande Optioner |
Kvarvarande Aktier |
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-08-13 | 2025-08-11 | 4 | Binkowski Brent | CVRX | Common Stock | D | 16 600 | 16 600 | ||||||
| 2025-05-19 | 2025-05-15 | 4 | Nielsen Kirk G. | CVRX | Common Stock | I | 5,4528 | 10 966 | 60 | 1 910 134 | ||||
| 2025-05-14 | 2025-05-14 | 4 | Nielsen Kirk G. | CVRX | Common Stock | I | 5,2347 | 61 200 | 320 | 1 899 168 | ||||
| 2025-05-14 | 2025-05-13 | 4 | Nielsen Kirk G. | CVRX | Common Stock | I | 5,2884 | 101 413 | 536 | 1 837 968 | ||||
| 2025-05-14 | 2025-05-12 | 4 | Nielsen Kirk G. | CVRX | Common Stock | I | 4,7885 | 25 200 | 121 | 1 736 555 | ||||
| 2025-05-13 | 2025-05-13 | 4 | Jain Mudit K. | CVRX | Common Stock | D | 5,2600 | 150 | 1 | 5 050 | ||||
| 2025-05-13 | 2025-05-12 | 4 | Jain Mudit K. | CVRX | Common Stock | D | 4,6573 | 1 500 | 7 | 4 900 | ||||
| 2025-05-12 | 2025-05-12 | 4 | Hykes Kevin | CVRX | Common Stock | D | 4,8400 | 5 000 | 24 | 133 000 | ||||
| 2025-03-04 | 2025-02-28 | 4 | Hykes Kevin | CVRX | Common Stock | D | 98 000 | 128 000 | ||||||
| 2025-03-04 | 2025-02-28 | 4 | John Robert Allen | CVRX | Common Stock | D | 55 000 | 55 000 | ||||||
| 2025-03-04 | 2025-02-28 | 4 | Adamson Philip B. | CVRX | Common Stock | D | 20 000 | 20 000 | ||||||
| 2025-03-04 | 2025-02-28 | 4 | OASHEIM JARED | CVRX | Common Stock | D | 22 000 | 37 447 | ||||||
| 2025-03-04 | 2025-02-28 | 4 | VERRASTRO PAUL | CVRX | Common Stock | D | 16 000 | 16 835 | ||||||
| 2024-11-21 | 2024-11-21 | 4 | VERRASTRO PAUL | CVRX | Common Stock | D | −1 040 | 835 | ||||||
| 2024-11-21 | 2024-11-19 | 4 | VERRASTRO PAUL | CVRX | Common Stock | D | 13,5781 | −1 430 | −19 | 1 875 | ||||
| 2024-11-21 | 2024-11-19 | 4 | VERRASTRO PAUL | CVRX | Common Stock | D | 5,1410 | 2 500 | 13 | 3 305 | ||||
| 2024-08-15 | 2024-08-15 | 4 | SLATTERY JOSEPH P | CVRX | Common Stock | D | 8,1000 | 3 000 | 24 | 30 645 | ||||
| 2024-08-08 | 2024-08-08 | 4 | SLATTERY JOSEPH P | CVRX | Common Stock | D | 8,2386 | 3 000 | 25 | 27 645 | ||||
| 2024-08-06 | 2024-08-06 | 4 | SLATTERY JOSEPH P | CVRX | Common Stock | D | 9,0900 | 2 500 | 23 | 24 645 | ||||
| 2024-08-05 | 2024-08-05 | 4 | Hykes Kevin | CVRX | Common Stock | D | 8,3589 | 30 000 | 251 | 30 000 | ||||
| 2024-03-27 | 2024-03-25 | 4 | Palmer Craig E. | CVRX | Common Stock | D | 0,2370 | 151 | 0 | 1 229 | ||||
| 2024-03-27 | 2024-03-25 | 4 | Palmer Craig E. | CVRX | Common Stock | D | 0,2370 | 404 | 0 | 1 078 | ||||
| 2024-03-27 | 2024-03-25 | 4 | Palmer Craig E. | CVRX | Common Stock | D | 0,2370 | 379 | 0 | 674 | ||||
| 2024-03-06 | 2024-02-29 | 4 | JOHNSON & JOHNSON By Johnson & Johnson Innovation - JJDC, Inc. | CVRX | Common Stock | I | 5,1410 | 79 | 0 | 4 103 430 | ||||
| 2024-03-06 | 2024-02-29 | 4 | JOHNSON & JOHNSON By Johnson & Johnson Innovation - JJDC, Inc. | CVRX | Common Stock | I | 3,9550 | 252 | 1 | 4 103 351 | ||||
| 2024-03-06 | 2024-02-29 | 4 | JOHNSON & JOHNSON By Johnson & Johnson Innovation - JJDC, Inc. | CVRX | Common Stock | I | 1,1860 | 142 | 0 | 4 103 099 | ||||
| 2024-03-06 | 2024-02-29 | 4 | JOHNSON & JOHNSON By Johnson & Johnson Innovation - JJDC, Inc. | CVRX | Common Stock | I | 1,1860 | 442 | 1 | 4 102 957 | ||||
| 2024-03-06 | 2024-02-29 | 4 | JOHNSON & JOHNSON By Johnson & Johnson Innovation - JJDC, Inc. | CVRX | Common Stock | I | 0,2370 | 300 | 0 | 4 102 515 | ||||
| 2024-03-06 | 2024-02-29 | 4 | JOHNSON & JOHNSON By Johnson & Johnson Innovation - JJDC, Inc. | CVRX | Common Stock | I | 0,2370 | 584 | 0 | 4 102 215 | ||||
| 2024-03-06 | 2024-02-29 | 4 | JOHNSON & JOHNSON By Johnson & Johnson Innovation - JJDC, Inc. | CVRX | Common Stock | I | 0,2370 | 489 | 0 | 4 101 631 | ||||
| 2024-03-06 | 2024-02-29 | 4 | JOHNSON & JOHNSON By Johnson & Johnson Innovation - JJDC, Inc. | CVRX | Common Stock | I | 0,2370 | 758 | 0 | 4 101 142 | ||||
| 2024-03-06 | 2024-02-29 | 4 | JOHNSON & JOHNSON By Johnson & Johnson Innovation - JJDC, Inc. | CVRX | Common Stock | I | 0,2370 | 85 | 0 | 4 100 384 | ||||
| 2024-03-06 | 2024-02-29 | 4 | JOHNSON & JOHNSON By Johnson & Johnson Innovation - JJDC, Inc. | CVRX | Common Stock | I | 0,2370 | 23 | 0 | 4 100 299 | ||||
| 2024-03-06 | 2024-02-29 | 4 | JOHNSON & JOHNSON By Johnson & Johnson Innovation - JJDC, Inc. | CVRX | Common Stock | I | 0,2370 | 71 | 0 | 4 100 276 | ||||
| 2024-03-06 | 2024-02-29 | 4 | JOHNSON & JOHNSON By Johnson & Johnson Innovation - JJDC, Inc. | CVRX | Common Stock | I | 0,2370 | 118 | 0 | 4 100 205 | ||||
| 2024-03-06 | 2024-02-29 | 4 | JOHNSON & JOHNSON By Johnson & Johnson Innovation - JJDC, Inc. | CVRX | Common Stock | I | 0,2370 | 165 | 0 | 4 100 087 | ||||
| 2024-03-06 | 2024-02-29 | 4 | JOHNSON & JOHNSON By Johnson & Johnson Innovation - JJDC, Inc. | CVRX | Common Stock | I | 0,2370 | 189 | 0 | 4 099 922 | ||||
| 2024-03-06 | 2024-02-29 | 4 | JOHNSON & JOHNSON By Johnson & Johnson Innovation - JJDC, Inc. | CVRX | Common Stock | I | 0,2370 | 158 | 0 | 4 099 733 | ||||
| 2024-03-06 | 2024-02-16 | 4 | JOHNSON & JOHNSON By Johnson & Johnson Innovation - JJDC, Inc. | CVRX | Common Stock | I | 25,8100 | −3 725 | −96 | 4 099 575 | ||||
| 2024-03-06 | 2024-02-16 | 4 | JOHNSON & JOHNSON By Johnson & Johnson Innovation - JJDC, Inc. | CVRX | Common Stock | I | 0,1580 | 607 725 | 96 | 4 103 300 | ||||
| 2024-02-27 | 2024-02-23 | 4 | VERRASTRO PAUL | CVRX | Common Stock | D | −1 650 | 805 | ||||||
| 2024-02-22 | 2024-02-20 | 4 | VERRASTRO PAUL | CVRX | Common Stock | D | 21,9050 | −2 545 | −56 | 2 455 | ||||
| 2024-02-22 | 2024-02-20 | 4 | VERRASTRO PAUL | CVRX | Common Stock | D | 5,1410 | 5 000 | 26 | 5 000 | ||||
| 2024-01-31 | 2024-01-29 | 4 | Yared Nadim | CVRX | Common Stock | D | 0,2370 | 1 945 | 0 | 26 255 | ||||
| 2024-01-31 | 2024-01-29 | 4 | Yared Nadim | CVRX | Common Stock | D | 0,2370 | 4 055 | 1 | 24 310 | ||||
| 2024-01-02 | 2023-12-28 | 4 | SLATTERY JOSEPH P | CVRX | Common Stock | D | 3,9550 | 96 | 0 | 22 145 | ||||
| 2024-01-02 | 2023-12-28 | 4 | SLATTERY JOSEPH P | CVRX | Common Stock | D | 1,1860 | 174 | 0 | 22 049 | ||||
| 2024-01-02 | 2023-12-28 | 4 | SLATTERY JOSEPH P | CVRX | Common Stock | D | 0,2370 | 1 456 | 0 | 21 875 | ||||
| 2024-01-02 | 2023-12-28 | 4 | SLATTERY JOSEPH P | CVRX | Common Stock | D | 0,2370 | 224 | 0 | 20 419 | ||||
| 2023-12-18 | 2023-12-14 | 4 | Behbahani Ali | CVRX | Common Stock | D | 0,2370 | 316 | 0 | 316 | ||||
| 2023-10-18 | 2023-10-16 | 4 | Galle Liz | CVRX | Common Stock | D | 0,2370 | 778 | 0 | 778 | ||||
| 2023-09-20 | 2023-09-18 | 4 | OASHEIM JARED | CVRX | Common Stock | D | 3,9550 | 5 335 | 21 | 15 447 | ||||
| 2023-09-20 | 2023-09-18 | 4 | OASHEIM JARED | CVRX | Common Stock | D | 0,2370 | 527 | 0 | 10 112 | ||||
| 2023-09-18 | 3 | Johnson & Johnson Innovation - JJDC, Inc. | CVRX | Common Stock | D | 3 495 575 | ||||||||
| 2023-09-18 | 2023-09-15 | 4 | Johnson & Johnson Innovation - JJDC, Inc. | CVRX | Common Stock | D | −3 495 575 | 0 | ||||||
| 2023-08-07 | 2023-08-03 | 4 | VERRASTRO PAUL | CVRX | Common Stock | D | 18,5549 | −628 | −12 | 0 | ||||
| 2023-08-02 | 2023-08-02 | 4 | VERRASTRO PAUL | CVRX | Common Stock | D | −2 000 | 628 | ||||||
| 2023-08-02 | 2023-07-31 | 4 | VERRASTRO PAUL | CVRX | Common Stock | D | 17,4948 | −1 122 | −20 | 2 628 | ||||
| 2023-08-02 | 2023-07-31 | 4 | VERRASTRO PAUL | CVRX | Common Stock | D | 5,1410 | 3 750 | 19 | 3 750 | ||||
| 2023-05-18 | 2023-05-16 | 4 | Palmer Craig E. | CVRX | Common Stock | D | 0,2370 | 295 | 0 | 295 | ||||
| 2023-01-13 | 2023-01-11 | 4 | Yared Nadim | CVRX | Common Stock | D | −7 080 | 20 255 | ||||||
| 2022-11-30 | 2022-11-30 | 4 | VERRASTRO PAUL | CVRX | Common Stock | D | −4 400 | 0 | ||||||
| 2022-11-30 | 2022-11-28 | 4 | VERRASTRO PAUL | CVRX | Common Stock | D | 12,5217 | −600 | −8 | 4 400 | ||||
| 2022-11-30 | 2022-11-28 | 4 | VERRASTRO PAUL | CVRX | Common Stock | D | 11,8545 | −4 000 | −47 | 5 000 | ||||
| 2022-11-30 | 2022-11-28 | 4 | VERRASTRO PAUL | CVRX | Common Stock | D | 5,1410 | 9 000 | 46 | 9 000 | ||||
| 2022-06-06 | 2022-06-02 | 4 | OASHEIM JARED | CVRX | Common Stock | D | 0,2370 | 2 633 | 1 | 9 585 | ||||
| 2022-06-06 | 2022-06-02 | 4 | OASHEIM JARED | CVRX | Common Stock | D | 0,2370 | 3 160 | 1 | 6 952 | ||||
| 2022-06-06 | 2022-06-02 | 4 | OASHEIM JARED | CVRX | Common Stock | D | 0,2370 | 2 528 | 1 | 3 792 | ||||
| 2022-06-06 | 2022-06-02 | 4 | OASHEIM JARED | CVRX | Common Stock | D | 0,2370 | 1 264 | 0 | 1 264 | ||||
| 2022-05-26 | 2022-05-24 | 4 | Nielsen Kirk G. | CVRX | Common Stock | I | 5,0498 | 8 070 | 41 | 1 711 355 | ||||
| 2022-05-23 | 2022-05-23 | 4 | Nielsen Kirk G. | CVRX | Common Stock | I | 5,0396 | 4 432 | 22 | 1 703 285 | ||||
| 2022-05-23 | 2022-05-20 | 4 | Nielsen Kirk G. | CVRX | Common Stock | I | 5,0354 | 13 387 | 67 | 1 698 853 | ||||
| 2022-05-23 | 2022-05-19 | 4 | Nielsen Kirk G. | CVRX | Common Stock | I | 5,0380 | 10 976 | 55 | 1 685 466 | ||||
| 2022-05-02 | 2022-05-02 | 4 | Nielsen Kirk G. | CVRX | Common Stock | I | 5,9701 | 41 988 | 251 | 1 612 186 | ||||
| 2022-05-02 | 2022-04-28 | 4 | Nielsen Kirk G. | CVRX | Common Stock | I | 5,9700 | 100 | 1 | 1 570 198 | ||||
| 2022-04-27 | 2022-04-25 | 4 | Yared Nadim | CVRX | Stock Option (right to buy) | D | 0,24 | −6 059 | 4 055 | |||||
| 2022-04-27 | 2022-04-25 | 4 | Yared Nadim | CVRX | Common Stock | D | 0,2370 | 6 059 | 1 | 27 335 | ||||
| 2022-04-26 | 2022-04-22 | 4 | BRINTNALL JOHN | CVRX | Stock Option (right to buy) | D | 0,24 | −1 264 | 0 | |||||
| 2022-04-26 | 2022-04-22 | 4 | BRINTNALL JOHN | CVRX | Stock Option (right to buy) | D | 0,24 | −3 792 | 0 | |||||
| 2022-04-26 | 2022-04-22 | 4 | BRINTNALL JOHN | CVRX | Stock Option (right to buy) | D | 0,24 | −2 221 | 0 | |||||
| 2022-04-26 | 2022-04-22 | 4 | BRINTNALL JOHN | CVRX | Stock Option (right to buy) | D | 0,24 | −2 584 | 702 | |||||
| 2022-04-26 | 2022-04-22 | 4 | BRINTNALL JOHN | CVRX | Stock Option (right to buy) | D | 0,24 | −1 590 | 685 | |||||
| 2022-04-26 | 2022-04-22 | 4 | BRINTNALL JOHN | CVRX | Common Stock | D | 0,2370 | 1 264 | 0 | 21 901 | ||||
| 2022-04-26 | 2022-04-22 | 4 | BRINTNALL JOHN | CVRX | Common Stock | D | 0,2370 | 3 792 | 1 | 20 637 | ||||
| 2022-04-26 | 2022-04-22 | 4 | BRINTNALL JOHN | CVRX | Common Stock | D | 0,2370 | 2 221 | 1 | 16 845 | ||||
| 2022-04-26 | 2022-04-22 | 4 | BRINTNALL JOHN | CVRX | Common Stock | D | 0,2370 | 2 584 | 1 | 14 624 | ||||
| 2022-04-26 | 2022-04-22 | 4 | BRINTNALL JOHN | CVRX | Common Stock | D | 0,2370 | 1 590 | 0 | 12 040 | ||||
| 2022-03-02 | 2022-02-28 | 4 | Jain Mudit K. | CVRX | Common Stock | D | 9,0327 | 600 | 5 | 3 400 | ||||
| 2022-02-28 | 2022-02-24 | 4 | Nielsen Kirk G. | CVRX | Common Stock | I | 8,2381 | 3 400 | 28 | 1 570 098 | ||||
| 2022-02-23 | 2022-02-23 | 4 | Nielsen Kirk G. | CVRX | Common Stock | I | 8,0404 | 38 200 | 307 | 1 566 698 | ||||
| 2022-02-23 | 2022-02-22 | 4 | Nielsen Kirk G. | CVRX | Common Stock | I | 7,9399 | 40 008 | 318 | 1 528 498 | ||||
| 2022-02-23 | 2022-02-18 | 4 | Nielsen Kirk G. | CVRX | Common Stock | I | 7,9233 | 26 659 | 211 | 1 488 490 | ||||
| 2022-02-10 | 2022-02-08 | 4 | BRUHN-DING DEAN | CVRX | Stock Option (right to buy) | D | 0,24 | −5 158 | 2 048 | |||||
| 2022-02-10 | 2022-02-08 | 4 | BRUHN-DING DEAN | CVRX | Stock Option (right to buy) | D | 0,24 | −2 275 | 0 | |||||
| 2022-02-10 | 2022-02-08 | 4 | BRUHN-DING DEAN | CVRX | Stock Option (right to buy) | D | 0,24 | −2 528 | 0 | |||||
| 2022-02-10 | 2022-02-08 | 4 | BRUHN-DING DEAN | CVRX | Stock Option (right to buy) | D | 0,24 | −2 528 | 0 | |||||
| 2022-02-10 | 2022-02-08 | 4 | BRUHN-DING DEAN | CVRX | Stock Option (right to buy) | D | 0,24 | −1 590 | 0 | |||||
| 2022-02-10 | 2022-02-08 | 4 | BRUHN-DING DEAN | CVRX | Stock Option (right to buy) | D | 0,24 | −378 | 0 | |||||
| 2022-02-10 | 2022-02-08 | 4 | BRUHN-DING DEAN | CVRX | Stock Option (right to buy) | D | 0,24 | −821 | 0 | |||||
| 2022-02-10 | 2022-02-08 | 4 | BRUHN-DING DEAN | CVRX | Stock Option (right to buy) | D | 0,24 | −1 169 | 0 | |||||
| 2022-02-10 | 2022-02-08 | 4 | BRUHN-DING DEAN | CVRX | Stock Option (right to buy) | D | 0,24 | −1 264 | 0 | |||||
| 2022-02-10 | 2022-02-08 | 4 | BRUHN-DING DEAN | CVRX | Stock Option (right to buy) | D | 0,24 | −1 264 | 0 | |||||
| 2022-02-10 | 2022-02-08 | 4 | BRUHN-DING DEAN | CVRX | Stock Option (right to buy) | D | 0,24 | −2 862 | 0 | |||||
| 2022-02-10 | 2022-02-08 | 4 | BRUHN-DING DEAN | CVRX | Stock Option (right to buy) | D | 0,24 | −12 383 | 4 128 | |||||
| 2022-02-10 | 2022-02-08 | 4 | BRUHN-DING DEAN | CVRX | Stock Option (right to buy) | D | 0,24 | −780 | 315 | |||||
| 2022-02-10 | 2022-02-08 | 4 | BRUHN-DING DEAN | CVRX | Common Stock | D | 0,2370 | 5 158 | 1 | 54 648 | ||||
| 2022-02-10 | 2022-02-08 | 4 | BRUHN-DING DEAN | CVRX | Common Stock | D | 0,2370 | 2 275 | 1 | 49 490 | ||||
| 2022-02-10 | 2022-02-08 | 4 | BRUHN-DING DEAN | CVRX | Common Stock | D | 0,2370 | 2 528 | 1 | 47 215 | ||||
| 2022-02-10 | 2022-02-08 | 4 | BRUHN-DING DEAN | CVRX | Common Stock | D | 0,2370 | 2 528 | 1 | 47 215 | ||||
| 2022-02-10 | 2022-02-08 | 4 | BRUHN-DING DEAN | CVRX | Common Stock | D | 0,2370 | 1 590 | 0 | 44 687 | ||||
| 2022-02-10 | 2022-02-08 | 4 | BRUHN-DING DEAN | CVRX | Common Stock | D | 0,2370 | 378 | 0 | 43 097 | ||||
| 2022-02-10 | 2022-02-08 | 4 | BRUHN-DING DEAN | CVRX | Common Stock | D | 0,2370 | 821 | 0 | 42 719 | ||||
| 2022-02-10 | 2022-02-08 | 4 | BRUHN-DING DEAN | CVRX | Common Stock | D | 0,2370 | 1 169 | 0 | 41 898 | ||||
| 2022-02-10 | 2022-02-08 | 4 | BRUHN-DING DEAN | CVRX | Common Stock | D | 0,2370 | 1 264 | 0 | 38 201 | ||||
| 2022-02-10 | 2022-02-08 | 4 | BRUHN-DING DEAN | CVRX | Common Stock | D | 0,2370 | 1 264 | 0 | 38 201 | ||||
| 2022-02-10 | 2022-02-08 | 4 | BRUHN-DING DEAN | CVRX | Common Stock | D | 0,2370 | 2 862 | 1 | 35 673 | ||||
| 2022-02-10 | 2022-02-08 | 4 | BRUHN-DING DEAN | CVRX | Common Stock | D | 0,2370 | 12 383 | 3 | 32 811 | ||||
| 2022-02-10 | 2022-02-08 | 4 | BRUHN-DING DEAN | CVRX | Common Stock | D | 0,2370 | 780 | 0 | 20 428 | ||||
| 2022-02-07 | 2022-02-03 | 4 | Yared Nadim | CVRX | Common Stock | D | 0,24 | −1 266 | 11 375 | |||||
| 2022-02-07 | 2022-02-03 | 4 | Yared Nadim | CVRX | Stock Option (right to buy) | D | 0,24 | −5 916 | 0 | |||||
| 2022-02-07 | 2022-02-03 | 4 | Yared Nadim | CVRX | Stock Option (right to buy) | D | 0,24 | −3 792 | 0 | |||||
| 2022-02-07 | 2022-02-03 | 4 | Yared Nadim | CVRX | Stock Option (right to buy) | D | 0,24 | −5 057 | 0 | |||||
| 2022-02-07 | 2022-02-03 | 4 | Yared Nadim | CVRX | Stock Option (right to buy) | D | 0,24 | −2 659 | 0 | |||||
| 2022-02-07 | 2022-02-03 | 4 | Yared Nadim | CVRX | Common Stock | D | 0,2370 | 1 266 | 0 | 21 276 | ||||
| 2022-02-07 | 2022-02-03 | 4 | Yared Nadim | CVRX | Common Stock | D | 0,2370 | 5 916 | 1 | 20 010 | ||||
| 2022-02-07 | 2022-02-03 | 4 | Yared Nadim | CVRX | Common Stock | D | 0,2370 | 3 792 | 1 | 14 094 | ||||
| 2022-02-07 | 2022-02-03 | 4 | Yared Nadim | CVRX | Common Stock | D | 0,2370 | 5 057 | 1 | 10 302 | ||||
| 2022-02-07 | 2022-02-03 | 4 | Yared Nadim | CVRX | Common Stock | D | 0,2370 | 2 659 | 1 | 5 245 | ||||
| 2022-01-20 | 2022-01-19 | 4 | Yared Nadim | CVRX | Common Stock | D | −10 500 | 2 586 | ||||||
| 2022-01-20 | 2022-01-18 | 4 | Yared Nadim | CVRX | Stock Option (right to buy) | D | 9,08 | 186 400 | 186 400 | |||||
| 2022-01-20 | 2022-01-18 | 4 | Galle Liz | CVRX | Stock Option (right to buy) | D | 9,08 | 25 900 | 25 900 | |||||
| 2022-01-20 | 2022-01-18 | 4 | BRUHN-DING DEAN | CVRX | Stock Option (right to buy) | D | 9,08 | 23 600 | 23 600 | |||||
| 2022-01-20 | 2022-01-18 | 4 | OASHEIM JARED | CVRX | Stock Option (right to buy) | D | 9,08 | 56 200 | 56 200 | |||||
| 2022-01-20 | 2022-01-18 | 4 | VERRASTRO PAUL | CVRX | Stock Option (right to buy) | D | 9,08 | 41 200 | 41 200 | |||||
| 2022-01-18 | 2022-01-13 | 4 | SLATTERY JOSEPH P | CVRX | Stock Option (right to buy) | D | 1,19 | −584 | 174 | |||||
| 2022-01-18 | 2022-01-13 | 4 | SLATTERY JOSEPH P | CVRX | Stock Option (right to buy) | D | 0,24 | −758 | 0 | |||||
| 2022-01-18 | 2022-01-13 | 4 | SLATTERY JOSEPH P | CVRX | Stock Option (right to buy) | D | 0,24 | −316 | 0 | |||||
| 2022-01-18 | 2022-01-13 | 4 | SLATTERY JOSEPH P | CVRX | Stock Option (right to buy) | D | 0,24 | −316 | 0 | |||||
| 2022-01-18 | 2022-01-13 | 4 | SLATTERY JOSEPH P | CVRX | Stock Option (right to buy) | D | 0,24 | −189 | 0 | |||||
| 2022-01-18 | 2022-01-13 | 4 | SLATTERY JOSEPH P | CVRX | Stock Option (right to buy) | D | 0,24 | −189 | 0 | |||||
| 2022-01-18 | 2022-01-13 | 4 | SLATTERY JOSEPH P | CVRX | Stock Option (right to buy) | D | 0,24 | −189 | 0 | |||||
| 2022-01-18 | 2022-01-13 | 4 | SLATTERY JOSEPH P | CVRX | Stock Option (right to buy) | D | 0,24 | −189 | 0 | |||||
| 2022-01-18 | 2022-01-13 | 4 | SLATTERY JOSEPH P | CVRX | Stock Option (right to buy) | D | 0,24 | −2 528 | 0 | |||||
| 2022-01-18 | 2022-01-13 | 4 | SLATTERY JOSEPH P | CVRX | Stock Option (right to buy) | D | 0,24 | −316 | 0 | |||||
| 2022-01-18 | 2022-01-13 | 4 | SLATTERY JOSEPH P | CVRX | Stock Option (right to buy) | D | 0,24 | −3 917 | 1 456 | |||||
| 2022-01-18 | 2022-01-13 | 4 | SLATTERY JOSEPH P | CVRX | Stock Option (right to buy) | D | 0,24 | −2 149 | 224 | |||||
| 2022-01-18 | 2022-01-13 | 4 | SLATTERY JOSEPH P | CVRX | Common Stock | D | 1,1860 | 584 | 1 | 20 195 | ||||
| 2022-01-18 | 2022-01-13 | 4 | SLATTERY JOSEPH P | CVRX | Common Stock | D | 0,2370 | 758 | 0 | 19 611 | ||||
| 2022-01-18 | 2022-01-13 | 4 | SLATTERY JOSEPH P | CVRX | Common Stock | D | 0,2370 | 316 | 0 | 18 853 | ||||
| 2022-01-18 | 2022-01-13 | 4 | SLATTERY JOSEPH P | CVRX | Common Stock | D | 0,2370 | 316 | 0 | 18 853 | ||||
| 2022-01-18 | 2022-01-13 | 4 | SLATTERY JOSEPH P | CVRX | Common Stock | D | 0,2370 | 189 | 0 | 18 537 | ||||
| 2022-01-18 | 2022-01-13 | 4 | SLATTERY JOSEPH P | CVRX | Common Stock | D | 0,2370 | 189 | 0 | 18 537 | ||||
| 2022-01-18 | 2022-01-13 | 4 | SLATTERY JOSEPH P | CVRX | Common Stock | D | 0,2370 | 189 | 0 | 18 348 | ||||
| 2022-01-18 | 2022-01-13 | 4 | SLATTERY JOSEPH P | CVRX | Common Stock | D | 0,2370 | 189 | 0 | 18 159 | ||||
| 2022-01-18 | 2022-01-13 | 4 | SLATTERY JOSEPH P | CVRX | Common Stock | D | 0,2370 | 2 528 | 1 | 17 781 | ||||
| 2022-01-18 | 2022-01-13 | 4 | SLATTERY JOSEPH P | CVRX | Common Stock | D | 0,2370 | 316 | 0 | 15 253 | ||||
| 2022-01-18 | 2022-01-13 | 4 | SLATTERY JOSEPH P | CVRX | Common Stock | D | 0,2370 | 3 917 | 1 | 14 621 | ||||
| 2022-01-18 | 2022-01-13 | 4 | SLATTERY JOSEPH P | CVRX | Common Stock | D | 0,2370 | 2 149 | 1 | 10 704 | ||||
| 2022-01-03 | 2021-12-30 | 4 | BRINTNALL JOHN | CVRX | Stock Option (right to buy) | D | 0,24 | −2 550 | 2 221 | |||||
| 2022-01-03 | 2021-12-30 | 4 | BRINTNALL JOHN | CVRX | Common Stock | D | 0,2370 | 2 550 | 1 | 10 450 | ||||
| 2021-12-30 | 2021-12-28 | 4 | Yared Nadim | CVRX | Stock Option (right to buy) | D | 0,24 | −2 080 | 2 659 | |||||
| 2021-12-30 | 2021-12-28 | 4 | Yared Nadim | CVRX | Common Stock | D | 0,2370 | 2 080 | 0 | 13 086 | ||||
| 2021-12-02 | 2021-11-30 | 4 | SLATTERY JOSEPH P | CVRX | Stock Option (right to buy) | D | 0,24 | −3 000 | 2 373 | |||||
| 2021-12-02 | 2021-11-30 | 4 | SLATTERY JOSEPH P | CVRX | Common Stock | D | 0,2400 | 3 000 | 1 | 8 555 | ||||
| 2021-11-29 | 2021-11-24 | 4 | BRUHN-DING DEAN | CVRX | Stock Option (right to buy) | D | 0,24 | −14 000 | 1 095 | |||||
| 2021-11-29 | 2021-11-24 | 4 | BRUHN-DING DEAN | CVRX | Common Stock | D | 0,2400 | 14 000 | 3 | 19 648 | ||||
| 2021-11-24 | 2021-11-22 | 4 | Yared Nadim | CVRX | Stock Option (right to buy) | D | 0,24 | −11 006 | 4 739 | |||||
| 2021-11-24 | 2021-11-22 | 4 | Yared Nadim | CVRX | Common Stock | D | 0,2400 | 11 006 | 3 | 11 006 | ||||
| 2021-11-19 | 2021-11-19 | 4 | Jain Mudit K. | CVRX | Common Stock | D | 13,6875 | 300 | 4 | 2 800 | ||||
| 2021-11-19 | 2021-11-18 | 4 | Jain Mudit K. | CVRX | Common Stock | D | 14,6327 | 875 | 13 | 2 500 | ||||
| 2021-08-16 | 2021-08-12 | 4 | Jain Mudit K. | CVRX | Common Stock | D | 19,7248 | 625 | 12 | 1 625 | ||||
| 2021-07-14 | 2021-07-12 | 4 | SHADAN MARTHA | CVRX | Stock Option (right to buy) | D | 20,10 | 24 885 | 24 885 | |||||
| 2021-07-14 | 2021-07-12 | 4 | SHADAN MARTHA | CVRX | Stock Option (right to buy) | D | 20,10 | 9 988 | 9 988 | |||||
| 2021-07-07 | 2021-07-02 | 4 | NEW ENTERPRISE ASSOCIATES 10 L P | CVRX | Series G Preferred Stock | D | −18 934 168 | 0 | ||||||
| 2021-07-07 | 2021-07-02 | 4 | NEW ENTERPRISE ASSOCIATES 10 L P | CVRX | Series F-2 Preferred Stock | D | −10 029 566 | 0 | ||||||
| 2021-07-07 | 2021-07-02 | 4 | NEW ENTERPRISE ASSOCIATES 10 L P | CVRX | Series E-2 Preferred Stock | D | −3 298 154 | 0 | ||||||
| 2021-07-07 | 2021-07-02 | 4 | NEW ENTERPRISE ASSOCIATES 10 L P | CVRX | Series D-2 Preferred Stock | D | −3 170 896 | 0 | ||||||
| 2021-07-07 | 2021-07-02 | 4 | NEW ENTERPRISE ASSOCIATES 10 L P | CVRX | Series C-2 Preferred Stock | D | −2 810 950 | 0 | ||||||
| 2021-07-07 | 2021-07-02 | 4 | NEW ENTERPRISE ASSOCIATES 10 L P | CVRX | Series B-2 Preferred Stock | D | −2 263 778 | 0 | ||||||
| 2021-07-07 | 2021-07-02 | 4 | NEW ENTERPRISE ASSOCIATES 10 L P | CVRX | Series A-2 Preferred Stock | D | −2 300 708 | 0 | ||||||
| 2021-07-07 | 2021-07-02 | 4 | NEW ENTERPRISE ASSOCIATES 10 L P | CVRX | Common Stock | D | 18,0000 | 225 500 | 4 059 | 2 026 083 | ||||
| 2021-07-07 | 2021-07-02 | 4 | NEW ENTERPRISE ASSOCIATES 10 L P | CVRX | Common Stock | D | 1 196 911 | 1 800 583 | ||||||
| 2021-07-07 | 2021-07-02 | 4 | NEW ENTERPRISE ASSOCIATES 10 L P | CVRX | Common Stock | D | 253 605 | 603 672 | ||||||
| 2021-07-07 | 2021-07-02 | 4 | NEW ENTERPRISE ASSOCIATES 10 L P | CVRX | Common Stock | D | 83 396 | 350 067 | ||||||
| 2021-07-07 | 2021-07-02 | 4 | NEW ENTERPRISE ASSOCIATES 10 L P | CVRX | Common Stock | D | 80 178 | 266 671 | ||||||
| 2021-07-07 | 2021-07-02 | 4 | NEW ENTERPRISE ASSOCIATES 10 L P | CVRX | Common Stock | D | 71 077 | 186 493 | ||||||
| 2021-07-07 | 2021-07-02 | 4 | NEW ENTERPRISE ASSOCIATES 10 L P | CVRX | Common Stock | D | 57 241 | 115 416 | ||||||
| 2021-07-07 | 2021-07-02 | 4 | NEW ENTERPRISE ASSOCIATES 10 L P | CVRX | Common Stock | D | 58 175 | 58 175 | ||||||
| 2021-07-07 | 2021-07-02 | 4 | NEA PARTNERS 10 L P See Note 4 | CVRX | Series G Preferred Stock | I | −1 470 416 | 0 | ||||||
| 2021-07-07 | 2021-07-02 | 4 | NEA PARTNERS 10 L P See Note 4 | CVRX | Series F-2 Preferred Stock | I | −777 752 | 0 | ||||||
| 2021-07-07 | 2021-07-02 | 4 | NEA PARTNERS 10 L P See Note 4 | CVRX | Series D-2 Preferred Stock | I | −410 162 | 0 | ||||||
| 2021-07-07 | 2021-07-02 | 4 | NEA PARTNERS 10 L P See Note 4 | CVRX | Series C-2 Preferred Stock | I | −369 115 | 0 | ||||||
| 2021-07-07 | 2021-07-02 | 4 | NEA PARTNERS 10 L P See Note 4 | CVRX | Series B-2 Preferred Stock | I | −590 551 | 0 | ||||||
| 2021-07-07 | 2021-07-02 | 4 | NEA PARTNERS 10 L P See Note 2 | CVRX | Series G Preferred Stock | I | −18 934 168 | 0 | ||||||
| 2021-07-07 | 2021-07-02 | 4 | NEA PARTNERS 10 L P See Note 2 | CVRX | Series F-2 Preferred Stock | I | −10 029 566 | 0 | ||||||
| 2021-07-07 | 2021-07-02 | 4 | NEA PARTNERS 10 L P See Note 2 | CVRX | Series E-2 Preferred Stock | I | −3 298 154 | 0 | ||||||
| 2021-07-07 | 2021-07-02 | 4 | NEA PARTNERS 10 L P See Note 2 | CVRX | Series D-2 Preferred Stock | I | −3 170 896 | 0 | ||||||
| 2021-07-07 | 2021-07-02 | 4 | NEA PARTNERS 10 L P See Note 2 | CVRX | Series C-2 Preferred Stock | I | −2 810 950 | 0 | ||||||
| 2021-07-07 | 2021-07-02 | 4 | NEA PARTNERS 10 L P See Note 2 | CVRX | Series B-2 Preferred Stock | I | −2 263 778 | 0 | ||||||
| 2021-07-07 | 2021-07-02 | 4 | NEA PARTNERS 10 L P See Note 2 | CVRX | Series A-2 Preferred Stock | I | −2 300 708 | 0 | ||||||
| 2021-07-07 | 2021-07-02 | 4 | NEA PARTNERS 10 L P See Note 4 | CVRX | Common Stock | I | 18,0000 | 24 750 | 446 | 173 388 | ||||
| 2021-07-07 | 2021-07-02 | 4 | NEA PARTNERS 10 L P See Note 4 | CVRX | Common Stock | I | 92 951 | 148 638 | ||||||
| 2021-07-07 | 2021-07-02 | 4 | NEA PARTNERS 10 L P See Note 4 | CVRX | Common Stock | I | 19 666 | 55 687 | ||||||
| 2021-07-07 | 2021-07-02 | 4 | NEA PARTNERS 10 L P See Note 4 | CVRX | Common Stock | I | 10 371 | 36 021 | ||||||
| 2021-07-07 | 2021-07-02 | 4 | NEA PARTNERS 10 L P See Note 4 | CVRX | Common Stock | I | 9 333 | 25 650 | ||||||
| 2021-07-07 | 2021-07-02 | 4 | NEA PARTNERS 10 L P See Note 4 | CVRX | Common Stock | I | 14 933 | 16 317 | ||||||
| 2021-07-07 | 2021-07-02 | 4 | NEA PARTNERS 10 L P See Note 2 | CVRX | Common Stock | I | 18,0000 | 225 500 | 4 059 | 2 026 083 | ||||
| 2021-07-07 | 2021-07-02 | 4 | NEA PARTNERS 10 L P See Note 2 | CVRX | Common Stock | I | 1 196 911 | 1 800 583 | ||||||
| 2021-07-07 | 2021-07-02 | 4 | NEA PARTNERS 10 L P See Note 2 | CVRX | Common Stock | I | 253 605 | 603 672 | ||||||
| 2021-07-07 | 2021-07-02 | 4 | NEA PARTNERS 10 L P See Note 2 | CVRX | Common Stock | I | 83 396 | 350 067 | ||||||
| 2021-07-07 | 2021-07-02 | 4 | NEA PARTNERS 10 L P See Note 2 | CVRX | Common Stock | I | 80 178 | 266 671 | ||||||
| 2021-07-07 | 2021-07-02 | 4 | NEA PARTNERS 10 L P See Note 2 | CVRX | Common Stock | I | 71 077 | 186 493 | ||||||
| 2021-07-07 | 2021-07-02 | 4 | NEA PARTNERS 10 L P See Note 2 | CVRX | Common Stock | I | 57 241 | 115 416 | ||||||
| 2021-07-07 | 2021-07-02 | 4 | NEA PARTNERS 10 L P See Note 2 | CVRX | Common Stock | I | 58 175 | 58 175 | ||||||
| 2021-07-06 | 2021-07-02 | 4 | GLAXOSMITHKLINE PLC | CVRX | Series G Preferred Stock | I | −10 055 408 | 0 | ||||||
| 2021-07-06 | 2021-07-02 | 4 | GLAXOSMITHKLINE PLC | CVRX | Series F-2 Preferred Stock | I | −1 081 434 | 0 | ||||||
| 2021-07-06 | 2021-07-02 | 4 | GLAXOSMITHKLINE PLC | CVRX | Series E-2 Preferred Stock | I | −331 399 | 0 | ||||||
| 2021-07-06 | 2021-07-02 | 4 | GLAXOSMITHKLINE PLC | CVRX | Series D-2 Preferred Stock | I | −589 939 | 0 | ||||||
| 2021-07-06 | 2021-07-02 | 4 | GLAXOSMITHKLINE PLC | CVRX | Series C-2 Preferred Stock | I | −513 312 | 0 | ||||||
| 2021-07-06 | 2021-07-02 | 4 | GLAXOSMITHKLINE PLC | CVRX | Series B-2 Preferred Stock | I | −59 527 | 0 | ||||||
| 2021-07-06 | 2021-07-02 | 4 | GLAXOSMITHKLINE PLC | CVRX | Common Stock | I | 18,0000 | 275 000 | 4 950 | 1 007 583 | ||||
| 2021-07-06 | 2021-07-02 | 4 | GLAXOSMITHKLINE PLC | CVRX | Common Stock | I | 635 646 | 732 583 | ||||||
| 2021-07-06 | 2021-07-02 | 4 | GLAXOSMITHKLINE PLC | CVRX | Common Stock | I | 27 345 | 96 937 | ||||||
| 2021-07-06 | 2021-07-02 | 4 | GLAXOSMITHKLINE PLC | CVRX | Common Stock | I | 8 380 | 69 592 | ||||||
| 2021-07-06 | 2021-07-02 | 4 | GLAXOSMITHKLINE PLC | CVRX | Common Stock | I | 14 917 | 61 212 | ||||||
| 2021-07-06 | 2021-07-02 | 4 | GLAXOSMITHKLINE PLC | CVRX | Common Stock | I | 12 979 | 46 295 | ||||||
| 2021-07-06 | 2021-07-02 | 4 | GLAXOSMITHKLINE PLC | CVRX | Common Stock | I | 1 505 | 33 316 | ||||||
| 2021-07-02 | 2021-07-02 | 4 | NEHRA JOHN M | CVRX | Common Stock | D | 18,0000 | 27 777 | 500 | 28 266 | ||||
| 2021-07-02 | 2021-07-01 | 4 | NEHRA JOHN M As custodian for UTMA account for grandson | CVRX | Common Stock | I | 25,8000 | 50 | 1 | 100 | ||||
| 2021-07-02 | 2021-06-30 | 4 | NEHRA JOHN M As custodian for UTMA account for grandson | CVRX | Common Stock | I | 27,4257 | 50 | 1 | 50 | ||||
| 2021-07-02 | 2021-07-02 | 4 | SLATTERY JOSEPH P | CVRX | Common Stock | D | 18,0000 | 5 555 | 100 | 5 555 | ||||
| 2021-07-02 | 2021-07-02 | 4 | Nielsen Kirk G. | CVRX | Series G Preferred Stock | I | −23 125 000 | 0 | ||||||
| 2021-07-02 | 2021-07-02 | 4 | Nielsen Kirk G. | CVRX | Common Stock | I | 1 461 831 | 1 461 831 | ||||||
| 2021-07-02 | 2021-07-02 | 4 | Jain Mudit K. | CVRX | Series G Preferred Stock | I | −11 250 000 | 0 | ||||||
| 2021-07-02 | 2021-07-02 | 4 | Jain Mudit K. | CVRX | Common Stock | I | 18,0000 | 222 222 | 4 000 | 933 383 | ||||
| 2021-07-02 | 2021-07-02 | 4 | Jain Mudit K. | CVRX | Common Stock | I | 711 161 | 711 161 | ||||||
| 2021-07-02 | 2021-07-01 | 4 | Jain Mudit K. | CVRX | Common Stock | D | 25,1000 | 1 000 | 25 | 1 000 | ||||
| 2021-07-02 | 2021-07-02 | 4 | Pardo Geoffrey B | CVRX | Series G Preferred Stock | I | −24 583 397 | 0 | ||||||
| 2021-07-02 | 2021-07-02 | 4 | Pardo Geoffrey B | CVRX | Common Stock | I | 18,0000 | 275 000 | 4 950 | 1 829 022 | ||||
| 2021-07-02 | 2021-07-02 | 4 | Pardo Geoffrey B | CVRX | Common Stock | I | 1 554 022 | 1 554 022 | ||||||
| 2021-07-02 | 2021-07-02 | 4 | BRINTNALL JOHN | CVRX | Series G-2 Preferred Stock | D | −89 518 | 0 | ||||||
| 2021-07-02 | 2021-07-02 | 4 | BRINTNALL JOHN | CVRX | Series F-2 Preferred Stock | D | −88 653 | 0 | ||||||
| 2021-07-02 | 2021-07-02 | 4 | BRINTNALL JOHN | CVRX | Common Stock | D | 5 658 | 7 900 | ||||||
| 2021-07-02 | 2021-07-02 | 4 | BRINTNALL JOHN | CVRX | Common Stock | D | 2 242 | 2 242 | ||||||
| 2021-07-02 | 2021-07-02 | 4 | JOHNSON & JOHNSON By Johnson & Johnson Innovation - JJDC, Inc. | CVRX | Series G Preferred Stock | I | −48 068 690 | 0 | ||||||
| 2021-07-02 | 2021-07-02 | 4 | JOHNSON & JOHNSON By Johnson & Johnson Innovation - JJDC, Inc. | CVRX | Series F-2 Preferred Stock | I | −7 587 828 | 0 | ||||||
| 2021-07-02 | 2021-07-02 | 4 | JOHNSON & JOHNSON By Johnson & Johnson Innovation - JJDC, Inc. | CVRX | Series E-2 Preferred Stock | I | −6 451 188 | 0 | ||||||
| 2021-07-02 | 2021-07-02 | 4 | JOHNSON & JOHNSON By Johnson & Johnson Innovation - JJDC, Inc. | CVRX | Series D-2 Preferred Stock | I | −4 032 259 | 0 | ||||||
| 2021-07-02 | 2021-07-02 | 4 | JOHNSON & JOHNSON By Johnson & Johnson Innovation - JJDC, Inc. | CVRX | Common Stock | I | 3 495 575 | 3 495 575 | ||||||
| 2021-07-01 | 2021-06-29 | 4 | VERRASTRO PAUL | CVRX | Stock Option (right to buy) | D | 18,00 | 19 000 | 19 000 | |||||
| 2021-07-01 | 2021-06-29 | 4 | BRUHN-DING DEAN | CVRX | Stock Option (right to buy) | D | 18,00 | 19 000 | 19 000 | |||||
| 2021-07-01 | 2021-06-29 | 4 | Galle Liz | CVRX | Stock Option (right to buy) | D | 18,00 | 19 700 | 19 700 | |||||
| 2021-07-01 | 2021-06-29 | 4 | Pardo Geoffrey B | CVRX | Stock Option (right to buy) | D | 18,00 | 10 382 | 10 382 | |||||
| 2021-07-01 | 2021-06-29 | 4 | Jain Mudit K. | CVRX | Stock Option (right to buy) | D | 18,00 | 10 382 | 10 382 | |||||
| 2021-07-01 | 2021-06-29 | 4 | NEHRA JOHN M | CVRX | Stock Option (right to buy) | D | 18,00 | 9 100 | 9 100 | |||||
| 2021-07-01 | 2021-06-29 | 4 | NEHRA JOHN M | CVRX | Stock Option (right to buy) | D | 18,00 | 10 382 | 10 382 | |||||
| 2021-07-01 | 2021-06-29 | 4 | BRINTNALL JOHN | CVRX | Stock Option (right to buy) | D | 18,00 | 18 300 | 18 300 | |||||
| 2021-07-01 | 2021-06-29 | 4 | Behbahani Ali | CVRX | Stock Option (right to buy) | D | 18,00 | 10 382 | 10 382 | |||||
| 2021-07-01 | 2021-06-29 | 4 | OASHEIM JARED | CVRX | Stock Option (right to buy) | D | 18,00 | 36 700 | 36 700 | |||||
| 2021-07-01 | 2021-06-29 | 4 | Yared Nadim | CVRX | Stock Option (right to buy) | D | 18,00 | 97 800 | 97 800 | |||||
| 2021-07-01 | 2021-06-29 | 4 | Nielsen Kirk G. | CVRX | Stock Option (right to buy) | D | 18,00 | 10 382 | 10 382 | |||||
| 2021-07-01 | 2021-06-29 | 4 | SLATTERY JOSEPH P | CVRX | Stock Option (right to buy) | D | 18,00 | 9 100 | 9 100 | |||||
| 2021-07-01 | 2021-06-29 | 4 | SLATTERY JOSEPH P | CVRX | Stock Option (right to buy) | D | 18,00 | 10 382 | 10 382 | |||||
| 2021-06-29 | 3 | SANDELL SCOTT D See Note 1 | CVRX | Common Stock | I | 1 384 | ||||||||
| 2021-06-29 | 3 | NEHRA JOHN M By trust | CVRX | Common Stock | I | 489 | ||||||||
| 2021-06-29 | 3 | BRINTNALL JOHN By trust | CVRX | Common Stock | I | 4 945 | ||||||||
| 2021-06-29 | 3 | BRINTNALL JOHN By spouse's trust | CVRX | Common Stock | I | 4 681 | ||||||||
| 2021-06-29 | 3 | BRUHN-DING DEAN | CVRX | Common Stock | D | 5 648 | ||||||||
| 2021-06-29 | 3 | Yared Nadim By trust for children | CVRX | Common Stock | I | 7 585 |
P
Köp på öppna marknaden eller privat köp av icke-derivatsäkerhet
S
Köp på öppna marknaden eller privat försäljning av icke-derivatsäkerhet
A
Bevilja, tilldelning eller annat förvärv av värdepapper från företaget (såsom en option)
C
Omvandling av derivat
D
Försäljning eller överföring av värdepapper tillbaka til företaget
F
Betalning av lösenpris eller skatteskuld med del av värdepapper som erhållits från bolaget
G
Överlåtelse av värdepapper från eller till insidern
K
Aktieswappar och liknande säkringsaffärer
M
Utövande eller omvandling av derivatsäkerhet som erhållits från företaget (som en option)
V
En transaktion friviligt rapporterad på schema 4
J
Andra (med en fotnot som beskriver transaktionen)
